deferoxamine has been researched along with Muscular Atrophy in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Muscular Atrophy: Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobak, K | 1 |
| Kasztura, M | 1 |
| Dziegala, M | 1 |
| Bania, J | 1 |
| Kapuśniak, V | 1 |
| Banasiak, W | 1 |
| Ponikowski, P | 1 |
| Jankowska, EA | 1 |
| Kondo, H | 1 |
| Miura, M | 1 |
| Kodama, J | 1 |
| Ahmed, SM | 1 |
| Itokawa, Y | 1 |
2 other studies available for deferoxamine and Muscular Atrophy
| Article | Year |
|---|---|
Iron limitation promotes the atrophy of skeletal myocytes, whereas iron supplementation prevents this process in the hypoxic conditions.
Topics: Animals; Cell Hypoxia; Cell Line; Deferoxamine; Desmin; Ferric Compounds; Gene Expression Regulation | 2018 |
Role of iron in oxidative stress in skeletal muscle atrophied by immobilization.
Topics: Animals; Deferoxamine; Glutathione; Hindlimb; Immobilization; Iron; Lipid Peroxidation; Male; Muscul | 1992 |